Skip to main content
رجوع
AHR logo

American Healthcare REIT, Inc.

جودة البيانات: 100%
AHR
NYSE Real Estate REIT - Healthcare Facilities
KWD 48.25
▲ KWD 0.18 (0.37%)
القيمة السوقية: 9.07B
نطاق اليوم
KWD 47.21 KWD 48.56
نطاق 52 أسبوعًا
KWD 26.48 KWD 54.67
حجم التداول
2,463,864
متوسط 50 يوم / 200 يوم
KWD 50.05 / KWD 44.37
الإغلاق السابق
KWD 48.07

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Real Estate (361 نظير)

المقياس السهم وسيط القطاع
P/E 130.0 11.1
P/B 2.7 0.8
ROE % 2.5 6.1
Net Margin % 3.1 19.9
Rev Growth 5Y % 15.6 7.0
D/E 0.5 0.9

السعر المستهدف للمحللين

Hold
KWD 53.330 +10.5%
Low: KWD 43.000 High: KWD 60.000
مكرر الربحية المستقبلي
61.5
ربحية السهم المستقبلية
KWD 0.782
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
2.6 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 0.000
KWD 0.000 – KWD 0.000
3.9 B 0
FY2029 KWD 1.620
KWD 1.420 – KWD 1.991
3.3 B 1
FY2028 KWD 1.280
KWD 1.122 – KWD 1.573
3.1 B 1

النقاط الرئيسية

Revenue grew 15.64% annually over 5 years — strong growth
ROE of 2.50% is below average
Debt/Equity of 0.48 — conservative balance sheet
Generating 165.88M in free cash flow
P/E of 129.97 — premium valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 6.49%

النمو

Revenue Growth (5Y)
15.64%
Revenue (1Y)9.15%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
2.50%
ROIC2.56%
Net Margin3.09%
Op. Margin7.43%

الأمان

Debt / Equity
0.48
Current RatioN/A
Interest Coverage1.96

التقييم

P/E Ratio
129.97
P/B Ratio2.73
EV/EBITDA62.84
Dividend Yield0.02%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 9.15% Revenue Growth (3Y) 10.26%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 15.64% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2.26B Net Income (TTM) 69.81M
ROE 2.50% ROA 1.29%
Gross Margin 1.76% Operating Margin 7.43%
Net Margin 3.09% Free Cash Flow (TTM) 165.88M
ROIC 2.56% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.48 Current Ratio N/A
Interest Coverage 1.96 Dividend Yield 0.02%
Valuation
P/E Ratio 129.97 P/B Ratio 2.73
P/S Ratio 4.01 PEG Ratio -0.46
EV/EBITDA 62.84 Dividend Yield 0.02%
Market Cap 9.07B Enterprise Value 10.55B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.26B 2.07B 1.86B 1.62B 1.26B
Net Income 69.81M -37.81M -71.47M -81.30M -47.79M
EPS (Diluted) 0.42 -0.29 -1.08 -1.23 -0.72
Gross Profit 39.69M 416.78M 356.83M 335.97M 182.01M
Operating Income 167.83M 136.79M 76.72M 90.59M 138.81M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 5.43B 4.49B 4.58B 4.79B 4.58B
Total Liabilities 2.07B 2.18B 3.12B 3.14B 2.75B
Shareholders' Equity 3.32B 2.26B 1.27B 1.40B 1.58B
Total Debt 1.59B 1.87B 3.02B 2.83B 2.50B
Cash & Equivalents 114.84M 76.70M 43.45M 65.05M 81.60M
Current Assets 319.15M 354.90M 297.10M 341.92M 330.74M
Current Liabilities 0.0 946.86M 1.47B 560.57M 1.11B